1,853 results on '"Bajaj, Jasmohan S"'
Search Results
2. The Role of Fecal Microbiota Transplantation in the Treatment of Liver Diseases
3. Gut-microbiome composition and function in progression of alcohol-associated liver disease: going beyond western experiences
4. Single nuclear RNA sequencing of terminal ileum in patients with cirrhosis demonstrates multi-faceted alterations in the intestinal barrier
5. Substitution of One Meat-based meal with Vegetarian and Vegan Alternatives Generates Lower Ammonia and Alters Metabolites in Cirrhosis: A Randomized Clinical Trial
6. Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis
7. Promises of microbiome-based therapies
8. Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
9. QuickStroop Predicts Time to Development of Overt Hepatic Encephalopathy and Related Hospitalizations in Patients With Cirrhosis
10. Comparing the CFIR-ERIC matching tool recommendations to real-world strategy effectiveness data: a mixed-methods study in the Veterans Health Administration
11. A Possible Reversible Cause of Cognitive Impairment: Undiagnosed Cirrhosis and Potential Hepatic Encephalopathy in Patients with Dementia
12. A Machine Learning Algorithm Avoids Unnecessary Paracentesis for Exclusion of SBP in Cirrhosis in Resource-limited Settings
13. Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis
14. Proton Pump Inhibitor use and Complications of Cirrhosis Are Linked with Distinct Gut Microbial Bacteriophage and Eukaryotic Viral Like Particle Signatures in Cirrhosis
15. The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance.
16. Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury
17. Hepatic Encephalopathy in Acute-on-Chronic Liver Failure
18. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
19. Actionable Solutions to Achieve Health Equity in Chronic Liver Disease
20. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis
21. Hospitalized Women With Cirrhosis Have More Nonhepatic Comorbidities and Associated Complications Than Men
22. Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans
23. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis
24. Hepatic Encephalopathy: Diagnostic Tools and Management Strategies
25. Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort
26. Characterizing patient-reported outcomes in veterans with cirrhosis.
27. Targeting the Gut Microbiome in Cirrhosis
28. Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials
29. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study
30. QuickStroop, a Shortened Version of EncephalApp, Detects Covert Hepatic Encephalopathy With Similar Accuracy Within One Minute
31. Obesity and GI Diseases: A Major Problem Weighing on Our Guts and Minds
32. Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence
33. Real-World Ammonia Testing in Hepatic Encephalopathy: Spreading Confusion From Patients to Clinicians Without Adding Value
34. Impact of Non-etiological Novel Therapies in the Course of Cirrhosis: Consensus Statements of Panel 4
35. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.
36. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi‐centre cohort
37. Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.
38. Serum and urinary metabolomics and outcomes in cirrhosis
39. Gut Microbiome and Alcohol-associated Liver Disease
40. Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy
41. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
42. Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis
43. Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis
44. Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice
45. Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax
46. Assessment of the spectrum of hepatic encephalopathy: A multicenter study
47. Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus.
48. Microbial Therapeutics in Liver Disease
49. Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial
50. Artificial Intelligence–Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.